MT-2 (Melanotan 2 Acetate) 10mg

MT-2 (Melanotan 2 Acetate) 10mg

Melanocortin receptor profile for pigmentation-pathway research. The Core PEPTIDE knowledge record describes Melanotan II / MT-2 as a synthetic alpha-MSH analog studied for skin pigmentation pathway models, with early human research identifying daily tanning-range references and commonly discussed nausea and flushing observations. MT-2 10 mg is mapped to LPPeptide SKU ML. 10. Current storefront values use our product data: 10 mg x 10 vials / box, $68.00 USD per box. LPPeptide reference specs: 10 mg x 10 vials.

Research context

The Core PEPTIDE knowledge record describes Melanotan II / MT-2 as a synthetic alpha-MSH analog studied for skin pigmentation pathway models, with early human research identifying daily tanning-range references and commonly discussed nausea and flushing observations. Research usually reviews melanocortin receptor activity, pigmentation models, appetite pathway context, and receptor selectivity.

Commonly matched with

ML10 is commonly reviewed alongside P41, XA10, WA3, BAC WATER, and PT-141. Keep each combination tied to a defined research objective and lot record. 

Compliance notice

ML10 is supplied for research use only. It is not for human or veterinary use, not for consumption, and statements on this page are reference context rather than medical claims.

Reference literature focus

The Core PEPTIDE knowledge record describes Melanotan II / MT-2 as a synthetic alpha-MSH analog studied for skin pigmentation pathway models, with early human research identifying daily tanning-range references and commonly discussed nausea and flushing observations. Research usually reviews melanocortin receptor activity, pigmentation models, appetite pathway context, and receptor selectivity.

Study design notes

Use the Core Peptide product knowledge record, current Core Peptide COA, and internal lab SOP to confirm identity, concentration, and endpoints before this material enters a study. The matched LPPeptide reference specification is 10 mg x 10 vials.

Core Peptide Handling Reference

Core PEPTIDE knowledge source: add 3.0 mL sterile water for about 3.33 mg/mL. The reference range is once daily 250-1000 mcg. At this concentration, 1 U is about 33.3 mcg.

Core PEPTIDE preparation pattern: use sterile technique, add diluent slowly down the vial wall, avoid foaming, roll gently until dissolved, label the preparation date, refrigerate at 2-8°C, and protect from light.

Preparation

MT-2 10 mg ships as lyophilized powder. Reconstitution note: Core PEPTIDE knowledge source: add 3.0 mL sterile water for about 3.33 mg/mL. The reference range is once daily 250-1000 mcg. At this concentration, 1 U is about 33.3 mcg. Record the final concentration and preparation date in the study log.

Storage

Lyophilized: -20 deg C or below, dry and dark. Reconstituted: 2-8°C, use within 1-2 weeks with bacteriostatic water, and protect from light. Follow the most current lot-specific handling record whenever it is available.

Safety observations

Commonly discussed observations include pigmentation changes, nausea signals, flushing, and melanocortin pathway effects.

Contraindications

Do not use ML10 outside qualified research workflows. Review the current SDS, COA, and protocol exclusions before handling.

Interaction review

Review combinations with PT-141 or other melanocortin pathway materials before use.

Certificate of Analysis

Each Core Peptide lot should be confirmed against current batch documentation before shipment or study use. This product page keeps ML10 visible so the SKU can be matched to the active COA.

Current catalog summary

• SKU: ML10
• Product: MT-2 10mg
• Storefront specification: 10mg x 10 vials /box
• Core Peptide reference specs: 10mg x 10 vials
• Listed box price: $68.00 USD
• Reference: Core Peptide product knowledge record

Testing checklist

• Peptide identity or material identity
• HPLC purity or assay result where applicable
• Batch ID and test date
• Sterility/endotoxin or accessory checks when applicable
• Residual solvent and handling notes where applicable